Cellix Technical TeamAug 23, 20214 min readBlood clots in severely ill COVID-19 patients caused by abnormal antibody responseNew study reveals blood clotting in critically ill COVID-19 may be caused by an excessive immune response rather than the virus itself.
Cellix Technical TeamMar 15, 20214 min readStandardised modelling of microclots in COVID-19 patientsResearchers set out to investigate if the spike protein interfered with blood flow, comparing naïve healthy PPP samples, with and without ad
Cellix Technical TeamOct 13, 20203 min readTrapped! Flow studies reveal Thrombosis targetThe researchers of this study focused on how recruited platelets interact with neutrophils and whether this promotes the onset of Deep Vein
Dmitry Kashanin, CTO, CellixAug 18, 20203 min readCellix Solutions model inflammation to accelerate your COVID-19 researchIn this newsletter, we continue to explore how Cellix’s VenaFlux Solutions can help researchers to study mechanisms involved in the...
Vivienne WilliamsJul 30, 20203 min readCellix Solutions model endothelial dysfunction for COVID-19 researchIn the current phase of Coronavirus SARS-Cov-2 pandemic, there is mounting research evidence that COVID-19 disease has a significant...
Dmitry Kashanin, CTO, CellixJul 22, 20202 min readCellix Solutions mimic microvascular thrombosis accelerating COVID-19 researchFor more than 15 years, Cellix has provided researchers with solutions for mimicking physiological conditions of human blood vessels and for